Publications:

FGFR3△7-9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma.

Cell Death & Disease

Jin, Zhijian Z; Feng, Haoran H; Liang, Juyong J; Jing, Xiaoqian X; Zhao, Qiwu Q; Zhan, Ling L; Shen, Baiyong B; Cheng, Xi X; Su, Liping L; Qiu, Weihua W

Publication Date: 2020-10-23

Variant appearance in text: TET2: Y1902F

PubMed Link: 33097695

Variant Present in the following documents:

• Main text
• 41419_2020_Article_3089.pdf

View BVdb publication page

MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.

Bmc Cancer

Dumas, Pierre-Yves PY; Mansier, Olivier O; Prouzet-Mauleon, Valerie V; Koya, Junji J; Villacreces, Arnaud A; Brunet de la Grange, Philippe P; Luque Paz, Damien D; Bidet, Audrey A; Pasquet, Jean-Max JM; Praloran, Vincent V; Salin, Franck F; Kurokawa, Mineo M; Mahon, François-Xavier FX; Cardinaud, Bruno B; Lippert, Eric E

Publication Date: 2018-11-12

Variant appearance in text: TET2: 5705A>T

PubMed Link: 30419846

Variant Present in the following documents:

View BVdb publication page

Mutations along a TET2 active site scaffold stall oxidation at 5-hydroxymethylcytosine.

Nature Chemical Biology

Liu, Monica Yun MY; Torabifard, Hedieh H; Crawford, Daniel J DJ; DeNizio, Jamie E JE; Cao, Xing-Jun XJ; Garcia, Benjamin A BA; Cisneros, G Andrés GA; Kohli, Rahul M RM

Publication Date: 2017-02

Variant appearance in text: TET2: Y1902F

PubMed Link: 27918559

Variant Present in the following documents:

• Main text

View BVdb publication page